Journals / Türkiye Diyabet ve Obezite Dergisi / 2021 / Cilt: 5 - Sayı: 1

Relationship Between Sirtuin 1 and Sirtuin 2 with Type 2 Diabetes

Sirtuin 1 ve Sirtuin 2’nin Tip 2 Diyabet ile İlişkisi

Pages
81–88
Publication Date
2022-11-06
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Sirtuins, which play a role in many physiological processes such as cell cycle regulation, apoptosis, mitochondrial biogenesis, lipid metabolism, fatty acid oxidation, cellular stress response, insulin secretion, aging, and inflammation, have been found to have a significant role in diabetes pathogenesis in recent years.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Diabetes mellitus is the most common endocrine disease in the world and in all age groups.
📊
Key Findings & Data:Type 2 diabetes is a disease that constitutes approximately 80-90% of diabetes cases and typically occurs in advanced ages.
💡
Conclusion & Impact:Sirtuins, which play a role in many physiological processes such as cell cycle regulation, apoptosis, mitochondrial biogenesis, lipid metabolism, fatty acid oxidation, cellular stress response, insulin secretion, aging, and inflammation, have been found to have a significant role in diabetes pathogenesis in recent years.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Sirtuin · SIRT1 · SIRT2

Abstract

Diabetes mellitus is the most common endocrine disease in the world and in all age groups. Type 2 diabetes is a disease that constitutes approximately 80-90% of diabetes cases and typically occurs in advanced ages. The pathogenesis of type 2 diabetes is quite complex and is still a matter of debate in many aspects. Heredity is polygenic and has a strong relationship with environmental factors. There is impaired insulin secretion and impaired insulin sensitivity. The Sirtuin family (SIRT) members are NAD+ dependent deacetylases that provide histone deacetylation and DNA stabilization in mammals, yeast and higher organisms. Studies have shown that it is associated with oncogenesis, longevity, metabolic regulation and neurodegenerative diseases. Sirtuins, which play a role in many physiological processes such as cell cycle regulation, apoptosis, mitochondrial biogenesis, lipid metabolism, fatty acid oxidation, cellular stress response, insulin secretion, aging, and inflammation, have been found to have a significant role in diabetes pathogenesis in recent years.

Özet

Diabetes mellitus, bütün dünyada ve bütün yaş gruplarında en sık görülen endokrin hastalıktır. Tip 2 diabet; diabet vakalarının yaklaşık %80-90’nı oluşturan ve tipik olarak ileri yaşlarda ortaya çıkan bir hastalıktır. Tip 2 diabet patogenezi oldukça karmaşıktır ve birçok yönden halen tartışma konusudur. Kalıtım poligeniktir ve çevresel faktörlerle güçlü bir ilişkisi mevcuttur. Bozulmuş insulin sekresyonu ve bozulmuş insulin sensitivitesi söz konusudur. Sirtuin ailesi (SIRT) NAD+ bağımlı deasetilazlar olup memelilerde, maya ve yüksek organizmalarda histon deasitalasyonu ve DNA stabilizasyonunu sağlar. Yapılan çalışmalarda onkogenez, uzun ömür, metabolik regülasyon ve nörodejeneratif hastalıklar ile ilişkili olduğu gösterilmiştir. Hücre döngüsünün düzenlenmesi, apoptoz, mitokondriyal biyogenez, lipid metabolizması, yağ asidi oksidasyonu, hücresel stres yanıtı, insülin salgılanması, yaşlanma ve inflamasyon gibi pek çok fizyolojik süreçte rol oynayan sirtuinlerin son yıllarda diyabet patogenezinde de oldukça önemli rolü olduğu tespit edilmiştir.

🔖

Cite This Article

ÇELİK, S. K., ULU, İ., ÇAKMAK, G. G. (2022). Relationship Between Sirtuin 1 and Sirtuin 2 with Type 2 Diabetes. Türkiye Diyabet ve Obezite Dergisi, Cilt: 5 - Sayı: 1, 81–88. https://ajindex.com/articles/627853

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (17)

  1. Saltiel AR, Kahn CR. Insulin signalling and the regulation of glucose and lipid metabolism. Nature. 2001;414(6865):799- 806
  2. Satman I, Omer B, Tutuncu Y, Kalaca S, Gedik S, Dinccag N ve ark. Twelve-year trends in the prevalence and risk factors of diabetes and prediabetes in Turkish adults. Eur J Epidemiol. 2013;(28):169-180
  3. Whiting DR, Guariguata L, Weil C, Shaw J. IDF Diabetes Atlas: Global estimates of the prevalence of diabetes for 2011 and 2030. Diabetes Res Clin Pract. 2011;94(3): 311-321
  4. Cho NH, Shaw JE, Karuranga S, Huang Y, da Rocha Fernandes JD, Ohlrogge AW, Malanda B. IDF Diabetes Atlas: Global estimates of diabetes prevalence for 2017 and projections for 2045. Diabetes Res Clin Pract. 2018;(138):271-281
  5. International Diabetes Federation. IDF Diabetes Atlas, 8th edn. Brussels, Belgium: International Diabetes Federation, 2017. http://www.diabetesatlas.org. Eriºim Tarihi: 10 Nisan 2018
  6. American Diabetes Association
  7. Improving care and promoting health in populations: Standards of Medical Care in Diabetes-2019. Diabetes Care. 2019;42(1):7-12
  8. Gan SK, Kriketos AD, Ellis BA, Thompson CH, Kraegen EW, Chisholm DJ. Changes in aerobic capacity and visceral fat but not myocyte lipid levels predict increased insulin action after exercise in overweight and obese men. Diabetes Care. 2003;26(6):1706-1713
  9. Williams KV, Kelley DE. Metabolic consequences of weight loss on glucose metabolism and insulin action in type 2 diabetes. Diabetes Obes Metab. 2000;(2):121-129
  10. Poulose N, Raju R. Sirtuin regulation in aging and injury. Biochim Biophys Acta. 2015;1852(11):2442-2455
  11. Michan S, Sinclair D. Sirtuins in mammals: Insights into their biological function. Biochem J. 2007;404(1):1-13
  12. Flick F, Lüscher B. Regulation of sirtuin function by posttranslational modifications. Front Pharmacol. 2012;3:29
  13. Roth M, Chen WY. Sorting out functions of sirtuins in cancer. Oncogene. 2014;33(13):1609-1620
  14. Chang HC, Guarente L. SIRT1 and other sirtuins in metabolism. Trends Endocrinol Metab. 2014;25(3):138-145
  15. Taddei A, Roche D, Bickmore WA, Almouzni G. The effects of histone deacetylase inhibitors on heterochromatin: Implications for anticancer therapy? EMBO Rep. 2005;6(6):520-524
  16. Palmirotta R, Cives M, Della-Morte D, et al. Sirtuins and cancer: Role in the epithelial-mesenchymal transition. Oxid Med Cell Longev. 2016;2016:3031459
  17. Roth M, Chen WY. Sorting out functions of sirtuins in cancer. Oncogene. 2014; 33(13):